First Tracks Biotherapeutics, Inc. (TRAX)
NMS · Healthcare · Biotechnology
$43.14
+0.87%
Closing price as of 2026-10-22 · Source: TEK2day Finance
Key Metrics
Market Cap
$1.54B
Shares Outstanding
35.7M
Exchange
NMS
Currency
USD
Quarterly Financials
| Metric | 2025-03-31 | 2025-06-30 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (51.3M) | (45.9M) | (52.8M) | (34.9M) |
| Net Income | (47.2M) | (42.4M) | (50.5M) | (33.4M) |
| Diluted EPS | $-1.36 | $-1.22 | $-1.45 | $-0.95 |
Annual Financials
| Metric | 2023-12-31 | 2024-12-31 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Operating Income | (118.5M) | (181.1M) |
| Net Income | (106.2M) | (163.7M) |
| Diluted EPS | $-3.05 | N/A |